Citigroup (C) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason.
Citigroup is undervalued, trading at 0.79x tangible book value, presenting a potential long-term investment if Jane Fraser's restructuring plan succeeds. Despite weak sentiment and regulatory issues, Citi's EPS growth and realistic RoTE targets show promise for future profitability. Economic risks include potential loan defaults and fluctuating net interest income, but stable rates and restructuring could improve margins.
Citigroup's (C) cost-cutting measures, technology modernization, and strategic exits have led to tangible improvements, positioning it as a "buy" despite macroeconomic challenges. C's strong CET1 and PCR metrics, along with a conservative loan-to-deposit ratio, indicate financial stability and resilience compared to competitors. Trading at a forward P/E of 9.3x, C is reasonably priced with potential for a rally to $80, supported by technical indicators.
In the most recent trading session, Citigroup (C) closed at $70.99, indicating a +0.94% shift from the previous trading day.
Sandy Weill on Thursday announced a new $50 million donation to create a cancer research and treatment hub focused on immunotherapy. The hub is in partnership with four leading research institutions.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Citigroup (C) have what it takes?
In the latest trading session, Citigroup (C) closed at $74.47, marking a +0.58% move from the previous day.
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
The S&P 500 index (^GSPC 0.08%) quickly fell into correction territory not too long ago. Dropping alongside the index were the shares of Citigroup (C 0.17%).
Citigroup (C) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
C reduces top executives' bonuses in 2024 tied to the bank's turnaround results and risk management fixes required by regulators.